AvroBio Inc
AVRO
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.24M
Close$
$2.19
56.1% upside
Current Fair Value
56.1% upsideUndervalued by 56.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.24 Million |
|---|---|
| Enterprise Value | $-227,023,404.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.05 |
| Beta | 1.22 |
| Outstanding Shares | 18,769,004 |
Return
| Return on Equity | -36.23% |
|---|---|
| Return on Assets | -33.86% |
| Return on Invested Capital | -38.69% |
Valuation & Multiples
| P/E Ratio | -7.01 |
|---|---|
| PEG | -11.94 |
| Price to Sales | - |
| Price to Book Ratio | 0.12 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 2.51 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | -0.02 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
February 26, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data